Open Access
Open access
Nature Communications, volume 11, issue 1, publication number 3618

Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein

Xiaoyi Fan 1, 2
Duanfang Cao 1
Lingfei Kong 1
Xinzheng Zhang 1, 2, 3
1
 
National Laboratory of Biomacromolecules, CAS Center for excellence in biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
3
 
Center for Biological Imaging, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
Publication typeJournal Article
Publication date2020-07-17
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor16.6
ISSN20411723, 20411723
General Chemistry
General Biochemistry, Genetics and Molecular Biology
General Physics and Astronomy
Abstract
Global emergencies caused by the severe acute respiratory syndrome coronavirus (SARS-CoV), Middle-East respiratory syndrome coronavirus (MERS-CoV) and SARS-CoV-2 significantly endanger human health. The spike (S) glycoprotein is the key antigen and its conserved S2 subunit contributes to viral entry by mediating host-viral membrane fusion. However, structural information of the post-fusion S2 from these highly pathogenic human-infecting coronaviruses is still lacking. We used single-particle cryo-electron microscopy to show that the post-fusion SARS-CoV S2 forms a further rotated HR1-HR2 six-helix bundle and a tightly bound linker region upstream of the HR2 motif. The structures of pre- and post-fusion SARS-CoV S glycoprotein dramatically differ, resembling that of the Mouse hepatitis virus (MHV) and other class I viral fusion proteins. This structure suggests potential targets for the development of vaccines and therapies against a wide range of SARS-like coronaviruses. The spike (S) protein of coronaviruses is responsible for receptor recognition and the fusion between the viral membrane and the of cell host membrane. Here the authors report a cryo-EM structure of SARS-CoV post-fusion S2 trimer, providing insights into the fusion mechanism that could be useful for therapeutic development against coronaviruses.

Top-30

Citations by journals

1
2
3
4
5
6
7
8
Viruses
8 publications, 4.65%
Frontiers in Immunology
7 publications, 4.07%
Vaccines
5 publications, 2.91%
ACS Omega
5 publications, 2.91%
eLife
5 publications, 2.91%
Science
4 publications, 2.33%
mBio
4 publications, 2.33%
Nature
3 publications, 1.74%
Scientific Reports
3 publications, 1.74%
npj Vaccines
3 publications, 1.74%
BMC Infectious Diseases
2 publications, 1.16%
Cell Research
2 publications, 1.16%
Current Opinion in Virology
2 publications, 1.16%
Immunity
2 publications, 1.16%
Structure
2 publications, 1.16%
PLoS Pathogens
2 publications, 1.16%
Cell
2 publications, 1.16%
Journal of the American Chemical Society
2 publications, 1.16%
Journal of Physical Chemistry B
2 publications, 1.16%
Chemical Society Reviews
2 publications, 1.16%
iScience
2 publications, 1.16%
Expert Opinion on Drug Discovery
1 publication, 0.58%
Journal of Nuclear Medicine
1 publication, 0.58%
ACS Biomaterials Science and Engineering
1 publication, 0.58%
Methods and Protocols
1 publication, 0.58%
Pathogens
1 publication, 0.58%
Polymers
1 publication, 0.58%
Frontiers in Pharmacology
1 publication, 0.58%
Microorganisms
1 publication, 0.58%
1
2
3
4
5
6
7
8

Citations by publishers

5
10
15
20
25
30
35
Cold Spring Harbor Laboratory
32 publications, 18.6%
Elsevier
30 publications, 17.44%
Springer Nature
20 publications, 11.63%
Multidisciplinary Digital Publishing Institute (MDPI)
19 publications, 11.05%
American Chemical Society (ACS)
15 publications, 8.72%
Frontiers Media S.A.
9 publications, 5.23%
Wiley
6 publications, 3.49%
Taylor & Francis
5 publications, 2.91%
American Association for the Advancement of Science (AAAS)
5 publications, 2.91%
American Society for Microbiology
5 publications, 2.91%
eLife Sciences Publications
5 publications, 2.91%
Public Library of Science (PLoS)
2 publications, 1.16%
Royal Society of Chemistry (RSC)
2 publications, 1.16%
Society of Nuclear Medicine and Molecular Imaging
1 publication, 0.58%
Biophysical Society
1 publication, 0.58%
Oxford University Press
1 publication, 0.58%
Walter de Gruyter
1 publication, 0.58%
Chinese Physical Society
1 publication, 0.58%
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.58%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.58%
Bioscientifica
1 publication, 0.58%
5
10
15
20
25
30
35
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Fan X. et al. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein // Nature Communications. 2020. Vol. 11. No. 1. 3618
GOST all authors (up to 50) Copy
Fan X., Cao D., Kong L., Zhang X. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein // Nature Communications. 2020. Vol. 11. No. 1. 3618
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41467-020-17371-6
UR - https://doi.org/10.1038/s41467-020-17371-6
TI - Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein
T2 - Nature Communications
AU - Fan, Xiaoyi
AU - Cao, Duanfang
AU - Kong, Lingfei
AU - Zhang, Xinzheng
PY - 2020
DA - 2020/07/17 00:00:00
PB - Springer Nature
IS - 1
VL - 11
SN - 2041-1723
SN - 2041-1723
ER -
BibTex
Cite this
BibTex Copy
@article{2020_Fan,
author = {Xiaoyi Fan and Duanfang Cao and Lingfei Kong and Xinzheng Zhang},
title = {Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein},
journal = {Nature Communications},
year = {2020},
volume = {11},
publisher = {Springer Nature},
month = {jul},
url = {https://doi.org/10.1038/s41467-020-17371-6},
number = {1},
doi = {10.1038/s41467-020-17371-6}
}
Found error?